An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancer
- PMID: 7360486
- DOI: 10.1159/000225424
An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancer
Abstract
A phase II study utilizing VP-16 and adriamycin in a randomized fashion tested the concept of synchronization of the drugs in treatment of metastatic breast cancer. Although there was a trend in median survival following the synchronized schedule, there was no significant difference in survival or progression-free intervals. The concept of synchronization was not established.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
